Company Overview

Development Stage

About the Company

百济神州(上海)医药研发有限公司是百济神州在上海设立的医药研发企业,其运营的上海医药研发中心于2020年11月20日在上海自贸区保税区域(外高桥)正式启用,系百济神州全球布局的第二个研发中心。该中心重点针对各类恶性肿瘤的大分子抗体药物开展研究,已建立起大规模的高标准实验室,打造从靶点验证、抗体发现到早期生产工艺研发(CMC)的一体化抗体药物发现流程。该研发中心位于中国(上海)自由贸易试验区日京路51号A幢。百济神州方面表示,上海医药研发中心的落成将进一步推动百济神州临床前研究的能力,为创新药物研发提供长期管线储备。

产品与服务
公司依托上海医药研发中心开展医药研发业务,重点针对各类恶性肿瘤的大分子抗体药物开展研究,已建立从靶点验证、抗体发现到早期生产工艺研发(CMC)的一体化抗体药物发现流程,为百济神州肿瘤创新药物研发提供临床前研究支撑。

荣誉资质
公司于2024年被认定为上海市技术先进型服务企业,享受企业所得税优惠政策,减按15%的税率计缴企业所得税,该证书自2024年12月至2026年12月有效期三年,自2024年起按15%税率计缴企业所得税。

企业文化
公司秉持百济神州“百创新药,济世惠民”的使命,以“患者为先”为核心价值观,将其作为一切工作的指导原则,致力于以更快速度、更可负担的价格为患者打造优质创新药物,为全世界的癌症患者提供高品质、可及且可负担的创新药物。

(本介绍内容由 DeepSeek AI 智能生成,仅供参考。)

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (4 open positions)

Manage
Note: How fast is hiring at 百济神州(上海)医药研发有限公司 growing? 2025: 136 openings (up 1260%), 2024: 10 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (119 records)

Manage
salary range: 2K - 50K, 96.6% of roles pay ¥2-10K
Note: salary statistics are based on 119 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 百济神州(上海)医药研发有限公司?96.6% of positions earn 2-10K, Undergraduate salary: ¥。销售类 average salary ¥8.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 百济神州(上海)医药研发有限公司? We provide: 医药代表,实习生,销售,pr,市场,地区经理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 销售类
    100% of total 100%
  • 医疗卫生/美容保健类
    58.8% of total 58.8%
  • 在校学生类
    23.5% of total 23.5%
  • 市场/公关/媒介类
    3.4% of total 3.4%

Education

  • 大专
    73.1% of total 73.1%
  • 本科
    24.4% of total 24.4%
  • 不限
    2.5% of total 2.5%

Experience

  • 1-3年
    52.9% of total 52.9%
  • 不限
    35.3% of total 35.3%
  • 3-5年
    11.8% of total 11.8%
View Detailed Analysis

What does 百济神州(上海)医药研发有限公司 require? Who is 百济神州(上海)医药研发有限公司 hiring? recruitment: 销售类占比最多占100%,其次是医疗卫生/美容保健类占58.8%. What education can get in at ? 大专占比最多占73.1%,其次是本科占24.4%. Work experience required at ? 1-3年占比最多占52.9%,其次是不限占35.3%. Where are the job locations at ? 北京占比最多占6.7%,其次是沈阳占5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 62,000万(元)
Legal Representative: XIAOBIN WU
Date Established:
Credit Code: 91310115MA1K4H0W7F
Registered Address: 中国(上海)自由贸易试验区日京路51号A幢二层

Partners & Suppliers

开展临床研究和转化医学合作 Source
供应商 学术合作
提供临床试验设计、数据管理和统计分析等CRO服务 Source
供应商 临床CRO
替雷利珠单抗海外权益授权,诺华支付首付款和里程碑款 Source
合作客户 授权合作
抗肿瘤药物临床试验合作 Source
供应商 学术合作
提供生物药委托生产(如替雷利珠单抗) Source
供应商 生产CDMO

People who follow this company also follow

Competitors (Similar Companies)

生物科技/生物工程 医药 分子靶向药物 药物研发
“Dedicated to the research and development of molecularly targeted drug”
“Continuously innovating to bring patients medicines that significantly”
医药 分子靶向药物 药物研发 生物医药
“汇聚全球资源、助力中国产业”
医疗器械 医疗科技 骨科 监护仪
生物制剂 仿制药 生产 研发
“Urban gas operator”
“Make good doctors and good medicines accessible and affordable for all”
医疗科技 医学科技 康复治疗 康复
“Innovators in science and technology”
储能设备 电力 电力电子 高压电源
租赁 资产管理 融资租赁 金融
医疗器械 贸易 健康产业 自动化技术
工程设计 交通设计 轨道交通设计 市政工程设计

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates